You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia

Showing 7951 - 7975 of 9,158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in Boston, Houston (recombinant interferon alfa, omacetaxine mepesuccinate)

Completed
  • Leukemia
  • recombinant interferon alfa
  • omacetaxine mepesuccinate
  • Boston, Massachusetts
  • +1 more
Feb 4, 2013

Lymphoma, Non-Hodgkin's Lymphoma, Hodgkin Disease Trial in United States (PCI-24781)

Completed
  • Lymphoma
  • +5 more
  • Chicago, Illinois
  • +4 more
Jun 17, 2013

Obtained in Acute Lymphoblastic Leukemia Treated at San Giovanni

Unknown status
  • Disease: Acute Lymphoblastic Leukemia
    • Torino, Italy
      Città della Salute e della Scienza di Torino
    Feb 5, 2013

    Lymphoblastic Leukemia, Acute, Lymphoma, Non-Hodgkin Trial in Berlin (R-Blocks, Protocol II-Ida)

    Completed
    • Lymphoblastic Leukemia, Acute
    • Lymphoma, Non-Hodgkin
    • R-Blocks
    • Protocol II-Ida
    • Berlin, Germany
      ALL-REZ Studienzentrale
    Feb 1, 2013

    Acute Lymphoblastic Leukemia Trial in Rotterdam (asparaginase, recombinant asparaginase)

    Completed
    • Acute Lymphoblastic Leukemia
    • Rotterdam, Netherlands
      Erasmus MC
    Feb 26, 2013

    Childhood Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous

    Completed
    • Childhood Chronic Myelogenous Leukemia
    • +3 more
    • omacetaxine mepesuccinate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 22, 2013

    Acute Promyelocytic Leukemia Trial in Chicago, Houston (Tamibarotene)

    Completed
    • Acute Promyelocytic Leukemia
    • Chicago, Illinois
    • +1 more
    Feb 11, 2013

    Conventional and Experimental Chemotherapy With Allogeneic

    Unknown status
    • Acute Myeloid Leukemia
      • Torino, Italy
        Città della Salute e della Scienza di Torino
      Feb 6, 2013

      Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Relapsing Chronic Myelogenous

      Completed
      • Blastic Phase Chronic Myelogenous Leukemia
      • +2 more
      • Los Angeles, California
        University of California at Los Angeles (UCLA )
      Jan 23, 2013

      Leukemia Trial in New York (filgrastim)

      Completed
      • Leukemia
      • filgrastim
      • New York, New York
        Herbert Irving Comprehensive Cancer Center at Columbia Universit
      Feb 1, 2013

      Studying Fentanyl in Patients With Cancer

      Terminated
      • Brain and Central Nervous System Tumors
      • +10 more
      • fentanyl citrate
      • pharmacological study
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Apr 16, 2013

      Leukemia Trial in New York (biological, drug, procedure)

      Completed
      • Leukemia
      • aldesleukin
      • +6 more
      • New York, New York
        Herbert Irving Comprehensive Cancer Center at Columbia Universit
      Feb 1, 2013

      B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in

      Completed
      • B-cell Chronic Lymphocytic Leukemia
      • +5 more
      • Chicago, Illinois
        Cancer and Leukemia Group B
      Jan 16, 2013

      Breast Cancer, Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

      Completed
      • Breast Cancer
      • +6 more
      • filgrastim
      • +4 more
      • Lexington, Kentucky
      • +3 more
      Apr 25, 2013

      Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Chronic Myelogenous

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +4 more
      • imatinib mesylate
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 22, 2013

      During Second Cycle of Decitabine Can Predict Response and

      Unknown status
      • Myelodysplastic Syndrome
        • Seoul, Korea, Republic of
          Division of Hematology Oncology, Samsung Medical Center
        Jan 23, 2014

        Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Transitional Cell Carcinoma of the

        Completed
        • Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
        • +3 more
        • arsenic trioxide
        • Chicago, Illinois
          Cancer and Leukemia Group B
        Jun 3, 2013

        Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

        Completed
        • Adult Acute Megakaryoblastic Leukemia (M7)
        • +16 more
        • San Antonio, Texas
          Southwest Oncology Group
        Jan 14, 2013

        Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in New York (sodium salicylate)

        Completed
        • Leukemia
        • +2 more
        • sodium salicylate
        • New York, New York
          Memorial Sloan-Kettering Cancer Center
        Jan 17, 2013

        Childhood Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous

        Completed
        • Childhood Chronic Myelogenous Leukemia
        • +2 more
        • imatinib mesylate
        • +2 more
        • Arcadia, California
          Children's Oncology Group
        Jan 16, 2013

        Recurrent Melanoma, Stage IV Melanoma Trial in Chicago (recombinant interleukin-12, recombinant interferon alfa, laboratory

        Completed
        • Recurrent Melanoma
        • Stage IV Melanoma
        • recombinant interleukin-12
        • +2 more
        • Chicago, Illinois
          Cancer and Leukemia Group B
        Jun 4, 2013

        Myeloma Trial (Carfilzomib, SAHA, Gemcitabine)

        Withdrawn
        • Myeloma
        • (no location specified)
        Jul 9, 2014

        Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Houston (decitabine, romidepsin)

        Completed
        • Chronic Myeloproliferative Disorders
        • +3 more
        • Houston, Texas
          M.D. Anderson Cancer Center at University of Texas
        Feb 8, 2013

        Leukemia Trial in Cleveland (cytarabine, daunorubicin HCl, imatinib mesylate)

        Completed
        • Leukemia
        • Cleveland, Ohio
          Cleveland Clinic Taussig Cancer Center
        Feb 12, 2013

        Leukemia, Lymphoproliferative Disorders Trial (Phenethyl Isothiocyanate (PEITC))

        Withdrawn
        • Leukemia
        • Lymphoproliferative Disorders
        • Phenethyl Isothiocyanate (PEITC)
        • (no location specified)
        Apr 12, 2013